Ayca Altincik
Overview
Explore the profile of Ayca Altincik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Besci O, Sevim R, Yuksek Acinikli K, Demir K, Catli G, Ozhan B, et al.
Klin Padiatr
. 2023 Dec;
237(1):11-20.
PMID: 38049102
Aim: We aimed to describe the clinical characteristics of patients with congenital combined pituitary hormone deficiency (CPHD) and evaluate the first-year growth responses of individuals with CPHD and isolated growth...
2.
Ince Becerir T, Altincik A, Ozhan B, Yuksel S
Paediatr Int Child Health
. 2021 Mar;
41(3):221-225.
PMID: 33715600
Subcutaneous fat necrosis (SFN) in the newborn is a form of panniculitis which presents with erythematous nodules and indurated plaques. Severe life-threatening hypercalcaemia can occur as a late complication. A...
3.
Tuhan H, Demircan T, Altincik A, Catli G, Kizilca O, Egeli T, et al.
Cardiol Young
. 2019 Jan;
29(3):319-324.
PMID: 30675832
Methods: The study included 44 children with the diagnosis of classic congenital adrenal hyperplasia and 39 healthy children whose age, pubertal status, and gender were similar to those of the...
4.
Altincik A, Karaca F, Onay H
Hormones (Athens)
. 2017 Jul;
16(2):205-208.
PMID: 28742509
Background And Objective: Persistent Müllerian duct syndrome (PMDS) is a relatively rare form of 46,XY disorder of sex development caused by the failure of formation, release or action of anti-Müllerian...
5.
Altincik A, Sayin O
J Clin Res Pediatr Endocrinol
. 2017 Jul;
10(1):8-12.
PMID: 28739555
Objective: Nesfatin-1, an anorexigenic neuropeptide, is expressed mainly in the central nervous system and in some peripheral tissues. The role of nesfatin-1 in energy balance has been investigated. Despite the...
6.
Altincik A, Akin M
J Pediatr Hematol Oncol
. 2016 May;
38(5):389-93.
PMID: 27164531
Present chelation protocols have increased the life quality and survival of the patients with β-thalassemia major (BTM). However, endocrine complications are still mostly experienced. The aim of this study was...
7.
Altincik A, Demir K, Catli G, Abaci A, Bober E
J Clin Res Pediatr Endocrinol
. 2016 Feb;
7(3):211-6.
PMID: 26831555
Objective: Hyperthyrotropinemia, which can be either a permanent or a transient state, is an asymptomatic condition and there is a controversy in management and long-term consequences. The aim of this...
8.
Altincik A, Tuglu B, Demir K, Catli G, Abaci A, Bober E
J Pediatr Endocrinol Metab
. 2016 Jan;
29(4):435-9.
PMID: 26812775
Background: The aim of this study is to determine the relationship between oxidative stress marker (8-iso-prostaglandine F2α) and glycemic indices computed from daily glucose monitoring data in children with type...
9.
Altincik A, Schlingmann K, Tosun M
J Clin Res Pediatr Endocrinol
. 2016 Jan;
8(1):101-4.
PMID: 26759217
Hereditary hypomagnesemia with secondary hypocalcemia (HSH) is a rare autosomal recessive disease caused by mutations in the transient receptor potential melastatin 6 (TRPM6) gene. Affected individuals present in early infancy...
10.
Anik A, Catli G, Abaci A, Sari E, Yesilkaya E, Korkmaz H, et al.
J Pediatr Endocrinol Metab
. 2015 Jul;
28(11-12):1265-71.
PMID: 26226118
Aim: To perform molecular analysis of pediatric maturity onset diabetes of the young (MODY) patients by next-generation sequencing, which enables simultaneous analysis of multiple genes in a single test, to...